Alpha Diagnostic International, Inc. Anti-Rat Vasoactive intestinal peptide receptor (VIPR2/VPAC2) IgG #1, aff pure VIPR21-A

Anti-Rat Vasoactive intestinal peptide receptor (VIPR2/VPAC2) IgG #1, aff pure General Information VIPR2, a 438aa (chr.7q36.3) protein in human (437aa in rat and mouse). The VIP receptor2 is also termed as type III PACAP receptor, mainly expressed in neural tissues. This is a receptor for VIP as well as PACAP 38 and 27, G proteins mediate the activity SugApplications Most Antibodies are tested by ELISA and Western. Additional applications, such as IHC or IP may have been tested and will be listed in the product data sheets or published research papers using our products. Typically, antibodies are tested against the SugSecAntibodies http://4adi.com/comm erce/ccc2480-seconda ry-antibodies-rabbit .htm SpeciesReactivity Mouse SugNegativeControl Non-immune Rabbit IgG Cat# 20009-1 Form Affinity purified IgG SugPositiveControl Recombinant or naturally purified proteins or cells of tissues expressing the protein under study can be used as positive controls for Western or IHC. Please review the ?General Information? tan under Product overview section. Control or blocking peptid Antigen 19-aa peptide from Rat VIPR2 (1); Designation (VIPR21-P, control peptide); epitope location ~ N-terminus, Extracellular domain SpCrossreactivity The rat VIPR21-P control peptide shows 94% homology with the mouse and 86% sequence identity with human VIPR2. No significant homology of VIPR21-P is observed with VIPR1 or proteins with other species. Antibody cross-reactivity in various species has not been studied For research use only, not for diagnostic or therapeutic use.